Global Sialorrhea Treatment Market is segmented By Treatment Type (Botulinum Toxin Injections (Xeomin, Myobloc), Oral Medications, Surgical Procedures, Radiation Therapy) ....
Market Size in USD
CAGR5.30%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.30% |
Market Concentration | High |
Major Players | Merz Pharmaceuticals, US WorldMeds, NeuroHealing, Proveca, Eisai (via Sloan Pharma) |
The sialorrhea treatment market is estimated to be valued at USD 771 Mn in 2024 and is expected to reach USD 1,110 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.30% from 2024 to 2031. The increasing prevalence of neurological diseases such as Parkinson's disease, amyotrophic lateral sclerosis and cerebral palsy is expected to drive the growth of this market during the forecast period.